Literature DB >> 24175438

Fatal vascular access hemorrhage: reducing the odds.

Lynda K Ball1.   

Abstract

Vascular access hemorrhage is not a frequently occurring complication associated with hemodialysis fistulas and grafts, but when it occurs, it can be fatal to patients and devastating to patients' families and dialysis unit staff members. The End Stage Renal Disease Notification of Death CMS-2746 forms indicated that between the years 2000 and 2006 (the most recent national data available), there were 1654 fatal vascular access hemorrhages. Specific issues that place patients at high risk for access rupture have been identified, and some are directly related to access physical assessment and cannulation. Recognizing at-risk accesses during physical assessment and improving site selection for needle placement can modify some risk factors for fatal vascular access hemorrhage and improve patient outcomes.

Entities:  

Mesh:

Year:  2013        PMID: 24175438

Source DB:  PubMed          Journal:  Nephrol Nurs J        ISSN: 1526-744X            Impact factor:   0.959


  4 in total

Review 1.  Diagnosis, Treatment, and Prevention of Hemodialysis Emergencies.

Authors:  Manish Saha; Michael Allon
Journal:  Clin J Am Soc Nephrol       Date:  2016-11-09       Impact factor: 8.237

2.  Use of a novel immediate access dialysis graft designed to prevent needle-related complications: A first-in-man case report.

Authors:  Shawn M Gage; Karl A Illig; John R Ross
Journal:  J Vasc Access       Date:  2020-05-05       Impact factor: 2.283

3.  Potentially survivable fatal vascular access hemorrhage with tourniquet use: A post-mortem analysis.

Authors:  Craig Goolsby; Luis E Rojas; Michael Andersen; Nathan Charlton; Laura Tilley; Jason Pasley; Todd E Rasmussen; Matthew J Levy
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-08-17

4.  Randomized pilot study to compare metal needles versus plastic cannulae in the development of complications in hemodialysis access.

Authors:  Rosa M Marticorena; Niki Dacouris; Sandra M Donnelly
Journal:  J Vasc Access       Date:  2018-02-28       Impact factor: 2.283

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.